{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:13:39Z","timestamp":1788509619967,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100024215","name":"ICMR - National Institute of Virology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xphs.2026.104311","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:16:44Z","timestamp":1777673804000},"page":"104311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zeolitic imidazolate frameworks for delivery of repurposed drugs with anti-chikungunya activity"],"prefix":"10.1016","volume":"115","author":[{"given":"Rutuja","family":"Jagtap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalichamy","family":"Alagarasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakil Ahmed","family":"Polash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.","family":"Kakade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atharva Manoj","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2688-3684","authenticated-orcid":false,"given":"Deepti","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2026.104311_bib0001","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11908-011-0180-1","article-title":"Chikungunya virus infection","volume":"13","author":"Simon","year":"2011","journal-title":"Curr Infect Dis Rep."},{"issue":"3","key":"10.1016\/j.xphs.2026.104311_bib0002","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI84417","article-title":"Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies","volume":"127","author":"Silva","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.xphs.2026.104311_bib0003","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.amjmed.2019.10.005","article-title":"Chronic chikungunya arthritis and rheumatoid arthritis: what they have in common","volume":"133","author":"Amaral","year":"2020","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.xphs.2026.104311_bib0004","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1590\/0074-02760170044","article-title":"Chikungunya virus: clinical aspects and treatment - a review","volume":"112","author":"da Cunha","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.xphs.2026.104311_bib0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-3618-2_22","article-title":"Antiviral strategies against Chikungunya virus","volume":"1426","author":"Abdelnabi","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.xphs.2026.104311_bib0006","first-page":"12","article-title":"Molecular epidemiology, evolution and reemergence of Chikungunya Virus in South Asia","author":"Sharif","year":"2021","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104311_bib0007","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ipha.2024.10.001","article-title":"Advancements in contemporary pharmacological innovation: mechanistic insights and emerging trends in drug discovery and development","volume":"3","author":"Majumder","year":"2025","journal-title":"Intell Pharmacy"},{"issue":"7","key":"10.1016\/j.xphs.2026.104311_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104390","article-title":"Therapeutic innovation in drug repurposing: challenges and opportunities","volume":"30","author":"Recino","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.xphs.2026.104311_bib0009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virusres.2019.02.011","article-title":"Drug repurposing for new, efficient, broad spectrum antivirals","volume":"264","author":"Garc\u00eda-Serradilla","year":"2019","journal-title":"Virus Res"},{"key":"10.1016\/j.xphs.2026.104311_bib0010","article-title":"Drug repurposing approach against chikungunya virus: an in vitro and in silico study","volume":"13","author":"Kasabe","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.xphs.2026.104311_bib0011","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semcancer.2020.02.003","article-title":"Turning liabilities into opportunities: off-target based drug repurposing in cancer","volume":"68","author":"Palve","year":"2021","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"10.1016\/j.xphs.2026.104311_bib0012","first-page":"13844","article-title":"Virus management using metal\u2013Organic framework-based technologies","volume":"15","author":"Boivin","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"issue":"16","key":"10.1016\/j.xphs.2026.104311_bib0013","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1039\/C4CS00094C","article-title":"Applications of metal\u2013organic frameworks in heterogeneous supramolecular catalysis","volume":"43","author":"Liu","year":"2014","journal-title":"Chem Soc Rev"},{"issue":"1","key":"10.1016\/j.xphs.2026.104311_bib0014","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1039\/C6CS00250A","article-title":"Multifunctional metal\u2013organic framework catalysts: synergistic catalysis and tandem reactions","volume":"46","author":"Huang","year":"2017","journal-title":"Chem Soc Rev"},{"issue":"1","key":"10.1016\/j.xphs.2026.104311_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12575-024-00229-2","article-title":"ZIF-8 nanoparticle: a valuable tool for improving gene delivery in sperm-mediated gene transfer","volume":"26","author":"Sameni","year":"2024","journal-title":"Biol Proced Online"},{"issue":"27","key":"10.1016\/j.xphs.2026.104311_bib0016","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1073\/pnas.0602439103","article-title":"Exceptional chemical and thermal stability of zeolitic imidazolate frameworks","volume":"103","author":"Park","year":"2006","journal-title":"Proc Natl Acad Sci"},{"issue":"17","key":"10.1016\/j.xphs.2026.104311_bib0017","doi-asserted-by":"crossref","first-page":"9292","DOI":"10.3390\/ijms25179292","article-title":"ZIF-8 as a pH-responsive nanoplatform for 5-fluorouracil delivery in the chemotherapy of oral squamous cell carcinoma","volume":"25","author":"Hao","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.xphs.2026.104311_bib0018","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.1021\/acsabm.1c00832","article-title":"Prospects of exploring the metal-organic framework for combating antimicrobial resistance","volume":"4","author":"Polash","year":"2021","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.xphs.2026.104311_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213420","article-title":"Targeting telomerase utilizing zeolitic imidazole frameworks as non-viral gene delivery agents across different cancer cell types","volume":"149","author":"Pyreddy","year":"2023","journal-title":"Biomater Adv"},{"key":"10.1016\/j.xphs.2026.104311_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2024.135227","article-title":"A biocompatible drug controlled release system based on \u03b2-cyclodextrin crosslinked magnetic lactose\/ZIF-8 metal-organic frameworks for cancer treatment","volume":"703","author":"Namazi","year":"2024","journal-title":"Colloids Surf A"},{"issue":"25","key":"10.1016\/j.xphs.2026.104311_bib0021","doi-asserted-by":"crossref","first-page":"9437","DOI":"10.1039\/c2ra21087h","article-title":"Cytotoxicity and slow release of the anti-cancer drug doxorubicin from ZIF-8","volume":"2","author":"Vasconcelos","year":"2012","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2026.104311_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1003448","article-title":"Targeted in vitro gene silencing of E2 and nsP1 genes of chikungunya virus by biocompatible zeolitic imidazolate framework","volume":"10","author":"Tagore","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"issue":"20","key":"10.1016\/j.xphs.2026.104311_bib0023","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1039\/D3MA00391D","article-title":"Impact of nucleic acid encapsulated MOF crystal phase on protein corona formation","volume":"4","author":"Ahmed Polash","year":"2023","journal-title":"Mater Adv"},{"issue":"10","key":"10.1016\/j.xphs.2026.104311_bib0024","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.3390\/molecules26103016","article-title":"Vitro antiviral activity of \u03b1-mangostin against Dengue Virus serotype-2 (DENV-2)","volume":"26","author":"Panda","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2026.104311_bib0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jiec.2020.08.021","article-title":"Zinc imidazolate framework-8 as a promising nitric oxide carrier","volume":"91","author":"Tanum","year":"2020","journal-title":"J Ind Eng Chem"},{"key":"10.1016\/j.xphs.2026.104311_bib0026","doi-asserted-by":"crossref","unstructured":"Wang Q, Sun Y, Li S, Zhang P, Yao Q. Synthesis and modification of ZIF-8 and its application in drug delivery and tumor therapy. RSC Adv. 10(62):37600\u201320. doi:10.1039\/d0ra07950b.","DOI":"10.1039\/D0RA07950B"},{"issue":"6","key":"10.1016\/j.xphs.2026.104311_bib0027","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00705-016-2829-4","article-title":"Diagnostic potential of monoclonal antibodies against the capsid protein of chikungunya virus for detection of recent infection","volume":"61","author":"Damle","year":"2016","journal-title":"Arch Virol"},{"issue":"9","key":"10.1016\/j.xphs.2026.104311_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002405","article-title":"Administration of E2 and NS1 siRNAs inhibit Chikungunya virus replication In vitro and protects mice infected with the virus","volume":"7","author":"Parashar","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"13","key":"10.1016\/j.xphs.2026.104311_bib0029","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1039\/C9SC05433B","article-title":"Phase dependent encapsulation and release profile of ZIF-based biocomposites","volume":"11","author":"Carraro","year":"2020","journal-title":"Chem Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104311_bib0030","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1021\/acsami.4c17664","article-title":"Phase characterization and bioactivity evaluation of nucleic acid-encapsulated biomimetically mineralized ZIF-8","volume":"17","author":"Polash","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"10.1016\/j.xphs.2026.104311_bib0031","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/acsami.7b16522","article-title":"MOF nanoparticles with encapsulated autophagy inhibitor in controlled drug delivery system for antitumor","volume":"10","author":"Chen","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"10.1016\/j.xphs.2026.104311_bib0032","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1021\/acsami.8b21698","article-title":"Antibacterial countermeasures via metal\u2013Organic framework-supported sustained therapeutic release","volume":"11","author":"Sava Gallis","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.xphs.2026.104311_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2024.103184","article-title":"Drug carrier wonders: synthetic strategies of zeolitic imidazolates frameworks (ZIFs) and their applications in drug delivery and anti-cancer activity","volume":"329","author":"Akhtar","year":"2024","journal-title":"Adv Colloid Interface Sci"},{"issue":"9","key":"10.1016\/j.xphs.2026.104311_bib0034","article-title":"Zeolitic Imidazolate frameworks based anticancer drug delivery system associated with dual action of Surface charge and Lewis Base Ligand","volume":"7","author":"Yang","year":"2024","journal-title":"Adv Therap"},{"key":"10.1016\/j.xphs.2026.104311_bib0035","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.2147\/IJN.S462480","article-title":"Biomimetic ZIF-8 nanoparticles: a novel approach for Biomimetic drug delivery systems","volume":"19","author":"Wang","year":"2024","journal-title":"Int J Nanomed"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:32:52Z","timestamp":1788507172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022354926001607"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104311","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zeolitic imidazolate frameworks for delivery of repurposed drugs with anti-chikungunya activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104311"}}